- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-6-mer
- Ligands
- 23 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x NAG- NAG- BMA- MAN- MAN- MAN- MAN- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-6)]alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN-MAN-MAN-MAN.6: 19 residues within 4Å:- Chain C: T.19, W.55, S.57, A.59, R.64, G.65, V.67, L.68, I.69, S.70, A.71, V.72, D.73, I.81, S.83, E.85
- Chain J: K.209, N.211, H.328
5 PLIP interactions:5 interactions with chain C- Hydrogen bonds: C:D.73, C:A.71, C:S.57, C:A.59, C:G.65, C:I.69, C:I.69
NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN-MAN-MAN-MAN.16: 19 residues within 4Å:- Chain E: T.19, W.55, S.57, S.58, A.59, R.64, G.65, V.67, L.68, I.69, S.70, A.71, V.72, D.73, I.81, E.85
- Chain K: K.209, N.211, H.328
4 PLIP interactions:4 interactions with chain E- Hydrogen bonds: E:D.73, E:A.71, E:A.59, E:G.65, E:I.69, E:I.69
NAG-NAG-BMA-MAN-MAN-MAN-MAN-MAN-MAN-MAN-MAN.25: 20 residues within 4Å:- Chain A: T.19, W.55, S.57, S.58, A.59, R.64, G.65, V.67, L.68, I.69, S.70, A.71, V.72, D.73, I.81, S.83, E.85
- Chain L: K.209, N.211, H.328
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:D.73, A:A.71, A:A.59, A:G.65, A:I.69, A:I.69
- 3 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN-MAN.7: 9 residues within 4Å:- Chain J: D.188, L.238, N.239, N.351, R.353, C.410, T.411, S.412
- Ligands: NAG.41
2 PLIP interactions:2 interactions with chain J- Hydrogen bonds: J:R.353, J:T.411
NAG-NAG-BMA-MAN-MAN.17: 11 residues within 4Å:- Chain K: P.189, V.231, L.238, N.239, N.351, C.352, R.353, C.410, T.411, S.412
- Ligands: NAG.52
2 PLIP interactions:2 interactions with chain K- Hydrogen bonds: K:R.353, K:T.411
NAG-NAG-BMA-MAN-MAN.26: 10 residues within 4Å:- Chain L: D.188, L.238, N.239, N.351, C.352, R.353, C.410, T.411, S.412
- Ligands: NAG.58
2 PLIP interactions:2 interactions with chain L- Hydrogen bonds: L:R.353, L:T.411
- 3 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA.10: 7 residues within 4Å:- Chain C: Q.1, H.3, Y.25, G.26
- Chain J: N.253, T.255, N.256
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:Q.1
NAG-NAG-BMA.18: 7 residues within 4Å:- Chain E: Q.1, H.3, Y.25, G.26
- Chain K: N.253, T.255, N.256
1 PLIP interactions:1 interactions with chain E- Hydrogen bonds: E:Q.1
NAG-NAG-BMA.27: 7 residues within 4Å:- Chain A: Q.1, H.3, Y.25, G.26
- Chain L: N.253, T.255, N.256
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:Q.1
- 29 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.33: 2 residues within 4Å:- Chain G: N.569, T.571
Ligand excluded by PLIPNAG.34: 1 residues within 4Å:- Chain H: N.569
Ligand excluded by PLIPNAG.35: 1 residues within 4Å:- Chain I: N.569
Ligand excluded by PLIPNAG.36: 3 residues within 4Å:- Chain G: S.499
- Chain J: E.55, N.56
Ligand excluded by PLIPNAG.37: 2 residues within 4Å:- Chain J: N.103, H.106
Ligand excluded by PLIPNAG.38: 5 residues within 4Å:- Chain J: N.126, R.303, K.304, Y.306, I.380
Ligand excluded by PLIPNAG.39: 2 residues within 4Å:- Chain J: N.137, Q.146
Ligand excluded by PLIPNAG.40: 2 residues within 4Å:- Chain J: N.206, N.218
Ligand excluded by PLIPNAG.41: 4 residues within 4Å:- Chain J: N.239, S.268, N.413
- Ligands: NAG-NAG-BMA-MAN-MAN.7
Ligand excluded by PLIPNAG.42: 2 residues within 4Å:- Chain J: N.278, I.299
Ligand excluded by PLIPNAG.43: 3 residues within 4Å:- Chain J: N.310, E.313, T.378
Ligand excluded by PLIPNAG.44: 3 residues within 4Å:- Chain H: S.499
- Chain K: E.55, N.56
Ligand excluded by PLIPNAG.45: 1 residues within 4Å:- Chain K: N.103
Ligand excluded by PLIPNAG.46: 2 residues within 4Å:- Chain K: N.126, T.128
Ligand excluded by PLIPNAG.47: 1 residues within 4Å:- Chain K: N.137
Ligand excluded by PLIPNAG.48: 2 residues within 4Å:- Chain K: N.206, N.218
Ligand excluded by PLIPNAG.49: 3 residues within 4Å:- Chain K: N.278, I.299, I.407
Ligand excluded by PLIPNAG.50: 4 residues within 4Å:- Chain K: N.310, T.312, E.313, T.378
Ligand excluded by PLIPNAG.51: 5 residues within 4Å:- Chain K: N.315, N.319, E.374, F.375, N.376
Ligand excluded by PLIPNAG.52: 4 residues within 4Å:- Chain K: N.239, S.268, N.413
- Ligands: NAG-NAG-BMA-MAN-MAN.17
Ligand excluded by PLIPNAG.53: 3 residues within 4Å:- Chain I: S.499
- Chain L: E.55, N.56
Ligand excluded by PLIPNAG.54: 2 residues within 4Å:- Chain L: N.103, H.106
Ligand excluded by PLIPNAG.55: 4 residues within 4Å:- Chain L: T.105, N.126, T.128, I.302
Ligand excluded by PLIPNAG.56: 1 residues within 4Å:- Chain L: N.137
Ligand excluded by PLIPNAG.57: 2 residues within 4Å:- Chain L: N.206, N.218
Ligand excluded by PLIPNAG.58: 4 residues within 4Å:- Chain L: N.239, S.268, N.413
- Ligands: NAG-NAG-BMA-MAN-MAN.26
Ligand excluded by PLIPNAG.59: 3 residues within 4Å:- Chain L: N.278, I.299, I.407
Ligand excluded by PLIPNAG.60: 4 residues within 4Å:- Chain L: N.310, T.312, E.313, T.378
Ligand excluded by PLIPNAG.61: 1 residues within 4Å:- Chain L: N.330
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Niu, J. et al., Structures and immune recognition of Env trimers from two Asia prevalent HIV-1 CRFs. Nat Commun (2023)
- Release Date
- 2023-08-09
- Peptides
- 8ANC195 Fab heavy chain: ACE
8ANC195 Fab light chain: BDF
X18 UFO gp41: GHIJKL - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
DE
HB
CD
EF
LG
RH
SI
TJ
XK
YL
Z
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-6-mer
- Ligands
- 23 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x NAG- NAG- BMA- MAN- MAN- MAN- MAN- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-6)]alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 29 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Niu, J. et al., Structures and immune recognition of Env trimers from two Asia prevalent HIV-1 CRFs. Nat Commun (2023)
- Release Date
- 2023-08-09
- Peptides
- 8ANC195 Fab heavy chain: ACE
8ANC195 Fab light chain: BDF
X18 UFO gp41: GHIJKL - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
DE
HB
CD
EF
LG
RH
SI
TJ
XK
YL
Z